Michel is the Managing Director and a Board Member of Theradiag, specialised in the diagnosis and monitoring of biotherapies.
Michel was previously the Deputy Managing Director and Financial Director of Neovacs, a biotechnology company listed on Alternext, Managing Director of Carmat, an innovative company developing a completely artificial heart, listed on Alternext and co-founded by Truffle Capital, Deputy Managing Director of Flamel Technologies, biotechnology company listed on the stock exchange (Nasdaq), Senior Vice President of the Aventis group (one of the leading international pharmaceutical groups) and Senior Vice President and Financial Director of Sanofi Pasteur (international leader in vaccines).
Michel is also Board member of France Biotech, the French association for life sciences entrepreneurs, since 2006, and of Néovacs and Carmat.
Graduate of EM Lyon and certified public accountant. Knight of the National Order of Merit.
Connexion espace partenaire